Related Experiment Video
Updated: Jun 14, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
A qualitative study of experiences among young adults who increased their cannabis use during the COVID-19 pandemic
Laura L Struik1, Alexia Armasu2, Genevieve Fortin3,4
1Faculty of Health and Social Development, School of Nursing, University of British Columbia, Okanagan Campus1628 Dickson Ave., Landmark 4 - 609, Kelowna, BC, V1Y 9X1, Canada. laura.struik@ubc.ca.
Background:
Young adults face unique vulnerabilities during major life disruptions like the COVID-19 pandemic. The pandemic contributed to increases in mental health challenges and substance use among young adults. This study explores the experiences of young adults who increased their cannabis use during the pandemic.
Methods:
Participants were recruited from the Nicotine Dependence in Teens (NDIT) study, and qualitative data were collected through semi-structured interviews conducted via Zoom. A total of 25 participants (ages 33-34) reporting increased cannabis use during the pandemic were included. Thematic analysis and gender-based analysis was employed to extract key themes.
Results:
Five themes emerged: (1) No disruption in cannabis use; (2) Cannabis use to manage declines in mental health; (3) Cannabis use to break up pandemic boredom; (4) Cannabis use as an expression of freedom; (5) Cannabis use as "another way to chill out."
Conclusions:
This research provides valuable perspectives on how major life disruptions, like the COVID-19 pandemic, influence cannabis use among young adults. The findings offer guidance for public health initiatives and highlight avenues for further investigation.
Related Concept Videos
Longitudinal Research
Cross-Sectional Research
Surveys
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Case Studies

